← SynDRA
CAFFEIC ACID PHENETHYL ESTER
SynDRA canonical compound SYN0003971 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | RELA |
|---|
| Mechanism of action | HIV integrase inhibitor |
|---|
All known targets
- RELA
- NFKB1
- NFKB2
- REL
- RELB
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- MAPK14
- KDM4E
- LCK
- LMNA
- LY96
- MAOA
- MAPK1
- MAPK3
- KCNK2
- MAPT
- MC3R
- MC4R
- MC5R
- MMP1
- MMP9
- KDM4A
- KCNH2
- ADORA1
- HRH1
- GLS
- GMNN
- HDAC6
- HMGCR
- HMOX1
- HPGD
- HRH2
- IDH1
- HSD17B10
- HSPA5
- HTR2A
- HTR2B
- HTR2C
- HTR6
- MPHOSPH8
- MTOR
- NFE2L2
- SNCA
- SIGMAR1
- SLC6A2
Cross-references
Synonyms
- Caffeic acid-phenethyl ester
- Phenethyl caffeate
- CAPE
- phenethyl 3-(3,4-dihydroxyphenyl)acrylate
- Capeee
- Phenylethyl caffeate
- caffeic acid phenylethyl ester
- UNII-G960R9S5SK
- 2-phenylethyl caffeate
- PHENETHYL CAFFEATE (CAPE)
- CHEBI:8062
- G960R9S5SK
- CHEMBL319244
- Caffeic acid 2-phenylethyl ester
- SWUARLUWKZWEBQ-VQHVLOKHSA-N
- 2-phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate
- Caffeic Acid Phenethyl Ester, Synthetic
- 2-Phenylethyl (2e)-3-(3,4-Dihydroxyphenyl
- 2-phenylethyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
- CAPE compound
- RefChem:573319
- DTXCID40810387
- caffeic acid phenyl ester
- Caffeic acid-phenylethyl ester
- (E)-phenethyl 3-(3,4-dihydroxyphenyl)acrylate
- MFCD00866470
- 2-Phenylethyl (2e)-3-(3,4-Dihydroxyphenyl)prop-2-Enoate
- SMR000326751
- Phenethyl (E)-caffeate
- SR-01000075785
- phenylethylcaffeate
- Caffeic acid ester
- QAP
- caffeic acidphenethylester
- caffeic acid phenethylester
- Epitope ID:914448
- caffeic acid phenylethylester
- Lopac0_000269
Look up CAFFEIC ACID PHENETHYL ESTER in the interactive SynDRA portal →